Caplacizumab Therapy in Immune Thrombotic Thrombocytopenic Purpura

被引：0
|
作者：
Reti, Marienn [1 ]
Sinkovits, Gyorgy [2 ]
Varkonyi, Andrea [1 ]
Kiraly, Agnes [1 ]
Farkas, Zita [1 ]
Bogsch, Luca [1 ]
Icleanu, Andreea-Adela [2 ]
Masszi, Tamas [2 ]
Valyi-Nagy, Istvan [1 ]
Prohaszka, Zoltan [2 ]
Remenyi, Peter Pal [1 ]
机构：
[1] Cent Hosp Southern Pest, Natl Inst Hematol & Infect Dis, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary
[2] Semmelweis Univ, Eotvos Lorand Res Network, Off Supported Res Grp, Dept Internal Med & Hematol, Budapest, Hungary
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186633
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Caplacizumab in the Therapy of thrombotic thrombocytopenic Purpura
    Gappa, Birgit
    TRANSFUSIONSMEDIZIN, 2019, 9 (02) : 86 - +
  • [2] Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
    Agosti, Pasquale
    Leo, Pasqualina De
    Capecchi, Marco
    Ferrari, Barbara
    Mancini, Ilaria
    Gattillo, Salvatore
    Trisolini, Silvia Maria
    Rinaldi, Erminia
    Podda, Gian Marco
    Prezioso, Lucia
    Salutari, Prassede
    Facchini, Luca
    Caramazza, Domenica
    Tolomelli, Giulia
    Artoni, Andrea
    Peyvandi, Flora
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [3] Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura
    Rodgers, George M.
    Berndt, Misa
    Fonteno, Megan
    Gilreath, Jeffrey A.
    JOURNAL OF BLOOD MEDICINE, 2023, 14 : 209 - 211
  • [4] Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab
    Schofield, Jeremy
    Shaw, Rebecca J.
    Lester, Will
    Thomas, Will
    Toh, Cheng-Hock
    Dutt, Tina
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1922 - 1925
  • [5] Caplacizumab for congenital thrombotic thrombocytopenic purpura
    Boothby, Aaron
    Mazepa, Marshall
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E420 - E421
  • [6] Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura
    Poullin, P.
    Bornet, C.
    Veyradier, A.
    Coppo, P.
    DRUGS OF TODAY, 2019, 55 (06) : 367 - 376
  • [7] Illustrated treatment of refractory immune thrombotic thrombocytopenic purpura with caplacizumab
    Tse, Brandon
    Buchholz, Megan
    Pavenski, Katerina
    BMJ CASE REPORTS, 2021, 14 (08)
  • [8] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Kaczmarek, Veronika
    Holle, Johannes
    Astudillo, Rebekka
    Kempf, Caroline
    Baler, Philip
    Mueller, Dominik
    PEDIATRIC NEPHROLOGY, 2019, 34 (09) : 1625 - 1628
  • [9] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
    Abdelghany, Mazin T.
    Baggett, Meridale V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (25): : 2497 - 2497
  • [10] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Veronika Kaczmarek
    Johannes Holle
    Rebekka Astudillo
    Caroline Kempf
    Philip Bufler
    Dominik Müller
    Pediatric Nephrology, 2019, 34 : 1625 - 1628
12345